[HTML][HTML] Evaluation of polymer nanoformulations in hepatoma therapy by established rodent models

Q Wang, P Zhang, Z Li, X Feng, C Lv, H Zhang… - Theranostics, 2019 - ncbi.nlm.nih.gov
Hepatoma is one of the most severe malignancies usually with poor prognosis, and many
patients are insensitive to the existing therapeutic agents, including the drugs for …

Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models.

Q Wang, P Zhang, Z Li, X Feng, C Lv, H Zhang… - Theranostics, 2019 - europepmc.org
Hepatoma is one of the most severe malignancies usually with poor prognosis, and many
patients are insensitive to the existing therapeutic agents, including the drugs for …

[PDF][PDF] Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models

Q Wang, P Zhang, Z Li, X Feng, C Lv, H Zhang, H Xiao… - pdfs.semanticscholar.org
Hepatoma is one of the most severe malignancies usually with poor prognosis, and many
patients are insensitive to the existing therapeutic agents, including the drugs for …

Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models

Q Wang, P Zhang, Z Li, X Feng, C Lv… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Hepatoma is one of the most severe malignancies usually with poor prognosis, and many
patients are insensitive to the existing therapeutic agents, including the drugs for …